{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:42:24Z","timestamp":1778658144920,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.cellsig.2025.111608","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T07:29:25Z","timestamp":1736839765000},"page":"111608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Unveiling the role of MDH1 in breast cancer drug resistance through single-cell sequencing and schottenol intervention"],"prefix":"10.1016","volume":"127","author":[{"given":"Jian","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cellsig.2025.111608_bb0005","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3892\/ijo.2020.5135","article-title":"Triple-negative breast cancer therapy: current and future perspectives (review)","volume":"57","author":"Won","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111608_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2025.111608_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106936","article-title":"Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery","volume":"107","author":"Zou","year":"2022","journal-title":"Int. J. Surg."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111608_bb0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer - expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111608_bb0025","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.cell.2018.03.041","article-title":"Chemoresistance evolution in triple-negative breast Cancer delineated by single-cell sequencing","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2025.111608_bb0030","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.cellsig.2025.111608_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.789914","article-title":"m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in acute myeloid leukemia","volume":"12","author":"Du","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2025.111608_bb0040","article-title":"Immunotherapy improves disease prognosis by affecting the tumor microenvironment: a bibliometric study","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2025.111608_bb0045","article-title":"N6-Methyladenosine-related LncRNAs are potential remodeling indicators in the tumor microenvironment and prognostic markers in osteosarcoma","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Immunol."},{"issue":"16","key":"10.1016\/j.cellsig.2025.111608_bb0050","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","article-title":"Sacituzumab Govitecan in metastatic triple-negative breast Cancer","volume":"384","author":"Bardia","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111608_bb0055","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast Cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111608_bb0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus chemotherapy in advanced triple-negative breast Cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111608_bb0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-023-01850-7","article-title":"Advances in immunotherapy for triple-negative breast cancer","volume":"22","author":"Liu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111608_bb0070","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41591-019-0432-4","article-title":"Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial","volume":"25","author":"Voorwerk","year":"2019","journal-title":"Nat. Med."},{"issue":"22","key":"10.1016\/j.cellsig.2025.111608_bb0075","doi-asserted-by":"crossref","first-page":"2001417","DOI":"10.1002\/advs.202001417","article-title":"CDK5 inhibition abrogates TNBC stem-cell property and enhances anti-PD-1 therapy","volume":"7","author":"Bei","year":"2020","journal-title":"Adv. Sci. (Weinh)."},{"key":"10.1016\/j.cellsig.2025.111608_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.814722","article-title":"The hypoxia-related signature predicts prognosis, pyroptosis and drug sensitivity of osteosarcoma","volume":"10","author":"Hu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cellsig.2025.111608_bb0085","doi-asserted-by":"crossref","first-page":"1027868","DOI":"10.3389\/fbioe.2022.1027868","article-title":"Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: a bibliometrics study","volume":"10","author":"Wang","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.cellsig.2025.111608_bb0090","doi-asserted-by":"crossref","first-page":"1064815","DOI":"10.3389\/fonc.2023.1064815","article-title":"Global scientific trends on matrix metalloproteinase and osteosarcoma: a bibliometric and visualized analysis","volume":"13","author":"Wu","year":"2023","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111608_bb0095","first-page":"4898","article-title":"An inflammatory response-related gene signature associated with immune status and prognosis of acute myeloid leukemia","volume":"14","author":"Wu","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.cellsig.2025.111608_bb0100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of triple-negative breast Cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111608_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13045-021-01223-x","article-title":"HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111608_bb0110","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","article-title":"A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer","volume":"27","author":"Bassez","year":"2021","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111608_bb0115","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41591-018-0078-7","article-title":"Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis","volume":"24","author":"Savas","year":"2018","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111608_bb0120","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"Wu","year":"2021","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111608_bb0125","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020107333","article-title":"A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast","volume":"40","author":"Pal","year":"2021","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111608_bb0130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/cas.13888","article-title":"Role of inhibitor of yes-associated protein 1 in triple-negative breast cancer with taxol-based chemoresistance","volume":"110","author":"Li","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cellsig.2025.111608_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156139","article-title":"Shikonin induces ferroptosis in osteosarcomas through the mitochondrial ROS-regulated HIF-1\u03b1\/HO-1 axis","volume":"135","author":"Lu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cellsig.2025.111608_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114864","article-title":"Dictamnine, a novel c-met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K\/AKT\/mTOR and MAPK signaling pathways","volume":"195","author":"Yu","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2025.111608_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105748","article-title":"Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4\/NLRP3\/GSDMD-dependent pyroptosis","volume":"170","author":"Yuan","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111608_bb0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13293-023-00540-9","article-title":"Sex differences in renal cell carcinoma: a single-cell analysis reveals exhausted CD8(+) T-cells highly infiltrated in males","volume":"14","author":"Ning","year":"2023","journal-title":"Biol. Sex Differ."},{"issue":"23","key":"10.1016\/j.cellsig.2025.111608_bb0155","article-title":"EZH2 inhibition enhances PD-L1 protein stability through USP22-mediated Deubiquitination in colorectal Cancer","volume":"11","author":"Huang","year":"2024","journal-title":"Adv. Sci. (Weinh)."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111608_bb0160","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1158\/2326-6066.CIR-17-0049","article-title":"Intratumoral STING activation with T-cell checkpoint modulation generates systemic antitumor immunity","volume":"5","author":"Ager","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111608_bb0165","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.ymthe.2023.08.015","article-title":"Chemerin triggers migration of a CD8 T cell subset with natural killer cell functions","volume":"31","author":"Ballet","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cellsig.2025.111608_bb0170","article-title":"High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Genet."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111608_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111647","article-title":"Chronic type I interferon signaling promotes lipid-peroxidation-driven terminal CD8(+) T cell exhaustion and curtails anti-PD-1 efficacy","volume":"41","author":"Chen","year":"2022","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111608_bb0180","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000494","article-title":"Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8(+) T cells","volume":"8","author":"Kumar","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111608_bb0185","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4143\/crt.2019.721","article-title":"T cells modified with CD70 as an alternative cellular vaccine for antitumor immunity","volume":"52","author":"Lee","year":"2020","journal-title":"Cancer Res. Treat."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111608_bb0190","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.immuni.2022.10.020","article-title":"The transcription factor IRF2 drives interferon-mediated CD8(+) T cell exhaustion to restrict anti-tumor immunity","volume":"55","author":"Lukhele","year":"2022","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111608_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112905","article-title":"The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR(+) CD8(+) effector state, and its deletion improves checkpoint blockade","volume":"42","author":"McClory","year":"2023","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111608_bb0200","article-title":"Small molecule inhibitors of MERTK and FLT3 induce cell cycle arrest in human CD8(+) T cells","volume":"9","author":"Powell","year":"2021","journal-title":"Vaccines (Basel)."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111608_bb0205","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.chom.2012.05.003","article-title":"Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection","volume":"11","author":"Wang","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111608_bb0210","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7150\/jca.90085","article-title":"BCG immunotherapy promotes tumor-derived T-cell activation through the FLT3\/FLT3LG pathway in bladder cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"J. Cancer"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111608_bb0215","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","article-title":"Overcoming endocrine resistance in breast Cancer","volume":"37","author":"Hanker","year":"2020","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111608_bb0220","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2021.12.023","article-title":"Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma","volume":"185","author":"Risom","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2025.111608_bb0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2021.07.010","article-title":"Breast cancer heterogeneity through the lens of single-cell analysis and spatial pathologies","volume":"82","author":"Zhao","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cellsig.2025.111608_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2017.07.002","article-title":"Immunotherapy for triple-negative breast cancer: existing challenges and exciting prospects","volume":"32","author":"Jia","year":"2017","journal-title":"Drug Resist. Updat."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111608_bb0235","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cell.2019.07.044","article-title":"Systematic immunotherapy target discovery using genome-scale in vivo CRISPR screens in CD8 T cells","volume":"178","author":"Dong","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111608_bb0240","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/annonc\/mdy517","article-title":"Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort a of the phase II KEYNOTE-086 study","volume":"30","author":"Adams","year":"2019","journal-title":"Ann. Oncol."},{"issue":"7967","key":"10.1016\/j.cellsig.2025.111608_bb0245","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41586-023-06199-x","article-title":"CD4(+) T cell-induced inflammatory cell death controls immune-evasive tumours","volume":"618","author":"Kruse","year":"2023","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111608_bb0250","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8(+) T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111608_bb0255","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1152\/physrev.00020.2018","article-title":"Cellular senescence: aging, Cancer, and injury","volume":"99","author":"Calcinotto","year":"2019","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111608_bb0260","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12943-018-0824-y","article-title":"SALL1 functions as a tumor suppressor in breast cancer by regulating cancer cell senescence and metastasis through the NuRD complex","volume":"17","author":"Ma","year":"2018","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111608_bb0265","doi-asserted-by":"crossref","first-page":"1725285","DOI":"10.1080\/20013078.2020.1725285","article-title":"Small extracellular vesicles deliver miR-21 and miR-217 as pro-senescence effectors to endothelial cells","volume":"9","author":"Mens\u00e0","year":"2020","journal-title":"J. Extracell Vesicles."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111608_bb0270","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.arr.2013.05.001","article-title":"MicroRNAs linking inflamm-aging, cellular senescence and cancer","volume":"12","author":"Olivieri","year":"2013","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111608_bb0275","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","article-title":"Microenvironment-driven metabolic adaptations guiding CD8(+) T cell anti-tumor immunity","volume":"56","author":"Park","year":"2023","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111608_bb0280","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ccell.2019.05.005","article-title":"Targeting tumors with IL-10 prevents dendritic cell-mediated CD8(+) T cell apoptosis","volume":"35","author":"Qiao","year":"2019","journal-title":"Cancer Cell"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682500021X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682500021X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T15:43:17Z","timestamp":1745854997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682500021X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":56,"alternative-id":["S089865682500021X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111608","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the role of MDH1 in breast cancer drug resistance through single-cell sequencing and schottenol intervention","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111608"}}